Asset Comparison and Correlation
|Alexion Pharmaceuticals Inc. vs Sangamo Biosciences Inc.|
Given investment horizon of 30 days, Alexion Pharmaceuticals Inc is expected to under-perform the Sangamo. But the stock apears to be less risky and, when comparing its historical volatility, Alexion Pharmaceuticals Inc is 1.43 times less risky than Sangamo. The stock trades about -0.18 of its potential returns per unit of risk. The Sangamo Biosciences Inc is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 784 in Sangamo Biosciences Inc on May 20, 2013 and sell it today you would earn a total of 34.00 from holding Sangamo Biosciences Inc or generate 4.34% return on investment over 30 days.
Over the last 30 days Alexion Pharmaceuticals Inc has generated negative risk-adjusted returns adding no value to investors with long positions.
Match-ups for Alexion
96% of all equities and portfolios perform better than Sangamo Biosciences Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Sangamo Biosciences Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 30 days.
Match-ups for Sangamo